Cargando…

High Pain Intensity is a Risk Factor of Non-Resolving TMD: A Three-Year Follow-Up of a Patient Group in a Norwegian Interdisciplinary Evaluation Program

PURPOSE: To investigate the outcome of patients with long-term refractory temporomandibular disorders (TMD) three years after a Norwegian interdisciplinary evaluation program with attention to patient satisfaction, function, pain, and psychosocial variables. PATIENTS AND METHODS: The study populatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Staniszewski, Kordian, Willassen, Lisa, Berge, Trond, Johansson, Anders, Schjødt, Borrik, Rosen, Annika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075908/
https://www.ncbi.nlm.nih.gov/pubmed/35529313
http://dx.doi.org/10.2147/JPR.S341861
_version_ 1784701791129042944
author Staniszewski, Kordian
Willassen, Lisa
Berge, Trond
Johansson, Anders
Schjødt, Borrik
Rosen, Annika
author_facet Staniszewski, Kordian
Willassen, Lisa
Berge, Trond
Johansson, Anders
Schjødt, Borrik
Rosen, Annika
author_sort Staniszewski, Kordian
collection PubMed
description PURPOSE: To investigate the outcome of patients with long-term refractory temporomandibular disorders (TMD) three years after a Norwegian interdisciplinary evaluation program with attention to patient satisfaction, function, pain, and psychosocial variables. PATIENTS AND METHODS: The study population consisted of 60 long-term refractory TMD patients who were investigated by a Norwegian interdisciplinary team. A questionnaire that covered medical history, function, pain, lifestyle factors, TMD-status and follow-up from their general medical practitioner (GMP) was sent to the patients three years after the evaluation. Questionnaires that assessed function (Mandibular Functional Index Questionnaire [MFIQ] and Roland Morrison Scale [RMS]), pain intensity (General Pain Intensity questionnaire [GPI]) and psychosocial factors (Hospital Anxiety and Depression scale [HADS]); a 2-item version of the Coping Strategies Questionnaire [CSQ]) were included in the package. RESULTS: Thirty-nine out of 60 TMD patients completed the questionnaires. Improvements in TMD symptoms were reported in 10 patients (26%), were unchanged in 16 patients (41%) and worsened in 13 patients (33%). Only 8 patients (21%) were satisfied with the follow-up of the suggested treatments from their GMP. Significant improvements of symptoms were noted in MFIQ (jaw function), GPI (including pain intensity at maximum and suffering from pain), and CSQ (pain related catastrophizing), in all 39 TMD patients as one group. However, a subgroup analysis showed that the significant improvements were mostly within patients who reported improvement of TMD symptoms. A high pain intensity at baseline was a significant risk factor (OR = 5.79, 95% CI: 1.34, 24.96) for patients who reported worsening of TMD symptoms at follow-up. CONCLUSION: High pain intensity at baseline was a significant risk factor for poorer recovery three years after an interdisciplinary evaluation. Our data support the notion that improved coping with TMD pain includes both decreased pain intensity, CSQ and MFIQ scores.
format Online
Article
Text
id pubmed-9075908
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-90759082022-05-07 High Pain Intensity is a Risk Factor of Non-Resolving TMD: A Three-Year Follow-Up of a Patient Group in a Norwegian Interdisciplinary Evaluation Program Staniszewski, Kordian Willassen, Lisa Berge, Trond Johansson, Anders Schjødt, Borrik Rosen, Annika J Pain Res Original Research PURPOSE: To investigate the outcome of patients with long-term refractory temporomandibular disorders (TMD) three years after a Norwegian interdisciplinary evaluation program with attention to patient satisfaction, function, pain, and psychosocial variables. PATIENTS AND METHODS: The study population consisted of 60 long-term refractory TMD patients who were investigated by a Norwegian interdisciplinary team. A questionnaire that covered medical history, function, pain, lifestyle factors, TMD-status and follow-up from their general medical practitioner (GMP) was sent to the patients three years after the evaluation. Questionnaires that assessed function (Mandibular Functional Index Questionnaire [MFIQ] and Roland Morrison Scale [RMS]), pain intensity (General Pain Intensity questionnaire [GPI]) and psychosocial factors (Hospital Anxiety and Depression scale [HADS]); a 2-item version of the Coping Strategies Questionnaire [CSQ]) were included in the package. RESULTS: Thirty-nine out of 60 TMD patients completed the questionnaires. Improvements in TMD symptoms were reported in 10 patients (26%), were unchanged in 16 patients (41%) and worsened in 13 patients (33%). Only 8 patients (21%) were satisfied with the follow-up of the suggested treatments from their GMP. Significant improvements of symptoms were noted in MFIQ (jaw function), GPI (including pain intensity at maximum and suffering from pain), and CSQ (pain related catastrophizing), in all 39 TMD patients as one group. However, a subgroup analysis showed that the significant improvements were mostly within patients who reported improvement of TMD symptoms. A high pain intensity at baseline was a significant risk factor (OR = 5.79, 95% CI: 1.34, 24.96) for patients who reported worsening of TMD symptoms at follow-up. CONCLUSION: High pain intensity at baseline was a significant risk factor for poorer recovery three years after an interdisciplinary evaluation. Our data support the notion that improved coping with TMD pain includes both decreased pain intensity, CSQ and MFIQ scores. Dove 2022-05-02 /pmc/articles/PMC9075908/ /pubmed/35529313 http://dx.doi.org/10.2147/JPR.S341861 Text en © 2022 Staniszewski et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Staniszewski, Kordian
Willassen, Lisa
Berge, Trond
Johansson, Anders
Schjødt, Borrik
Rosen, Annika
High Pain Intensity is a Risk Factor of Non-Resolving TMD: A Three-Year Follow-Up of a Patient Group in a Norwegian Interdisciplinary Evaluation Program
title High Pain Intensity is a Risk Factor of Non-Resolving TMD: A Three-Year Follow-Up of a Patient Group in a Norwegian Interdisciplinary Evaluation Program
title_full High Pain Intensity is a Risk Factor of Non-Resolving TMD: A Three-Year Follow-Up of a Patient Group in a Norwegian Interdisciplinary Evaluation Program
title_fullStr High Pain Intensity is a Risk Factor of Non-Resolving TMD: A Three-Year Follow-Up of a Patient Group in a Norwegian Interdisciplinary Evaluation Program
title_full_unstemmed High Pain Intensity is a Risk Factor of Non-Resolving TMD: A Three-Year Follow-Up of a Patient Group in a Norwegian Interdisciplinary Evaluation Program
title_short High Pain Intensity is a Risk Factor of Non-Resolving TMD: A Three-Year Follow-Up of a Patient Group in a Norwegian Interdisciplinary Evaluation Program
title_sort high pain intensity is a risk factor of non-resolving tmd: a three-year follow-up of a patient group in a norwegian interdisciplinary evaluation program
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075908/
https://www.ncbi.nlm.nih.gov/pubmed/35529313
http://dx.doi.org/10.2147/JPR.S341861
work_keys_str_mv AT staniszewskikordian highpainintensityisariskfactorofnonresolvingtmdathreeyearfollowupofapatientgroupinanorwegianinterdisciplinaryevaluationprogram
AT willassenlisa highpainintensityisariskfactorofnonresolvingtmdathreeyearfollowupofapatientgroupinanorwegianinterdisciplinaryevaluationprogram
AT bergetrond highpainintensityisariskfactorofnonresolvingtmdathreeyearfollowupofapatientgroupinanorwegianinterdisciplinaryevaluationprogram
AT johanssonanders highpainintensityisariskfactorofnonresolvingtmdathreeyearfollowupofapatientgroupinanorwegianinterdisciplinaryevaluationprogram
AT schjødtborrik highpainintensityisariskfactorofnonresolvingtmdathreeyearfollowupofapatientgroupinanorwegianinterdisciplinaryevaluationprogram
AT rosenannika highpainintensityisariskfactorofnonresolvingtmdathreeyearfollowupofapatientgroupinanorwegianinterdisciplinaryevaluationprogram